ATF3 and cardiac hypertrophy: Kalfon et al, (2019) found that mice with ATF3 gene defects experience maladaptive heart remodeling and reduced cardiac hypertrophy. Therefore, treatment targeting ATF3 activity may be beneficial for the recovery of cardiac function.